Sethuraman Natarajan
President, Research &Develop. | Chief Scientific Officer
1 company
Insider Signal Score
83
ExcellentTrades Analyzed
19
12M Win Rate
100.0%
Avg 3M Return
+14.0%
Avg 12M Return
+51.1%
Sethuraman Natarajan is a President, Research &Develop. at Entrada Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $1.5M based on current market prices.
Holdings by Company
TRDAMay 4, 2026
Current Shares216.3K
Value$1.53M
Net Activity-110,025
Bought: 0Sold: 110.0K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell | 25,907 | $15.39 | $398,809.77 | -10.7% | -58.5% | - | |
| Dec 3, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell | 15,891 | $20.18 | $320,619.70 | -3.3% | -43.8% | -50.1% | |
| Nov 13, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell | 4,109 | $20.03 | $82,299.94 | -1.3% | -38.7% | -56.0% | |
| Nov 6, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell | 18,219 | $18.62 | $339,280.66 | -2.6% | -27.3% | -62.8% | |
| Oct 16, 2024 | TRDA Entrada Therapeutics, Inc. | President, Research &Develop. | Sell | 600 | $18.00 | $10,800.00 | -0.3% | -29.3% | -65.0% | |
| Sep 9, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,242 | $15.12 | $49,003.59 | -0.9% | +43.2% | -65.8% | |
| Jul 15, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,238 | $18.00 | $22,284.00 | -0.3% | -0.2% | -64.3% | |
| May 20, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell | 18,980 | $15.16 | $287,694.89 | -3.1% | +7.8% | -46.2% | |
| Jul 11, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell | 17,878 | $18.03 | $322,389.28 | -5.3% | -20.9% | -12.6% | |
| Apr 17, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,961 | $18.00 | $71,315.82 | -2.3% | -7.9% | -29.4% |